ERAS
Erasca Inc.
Company Overview
| Mkt Cap | $692.16M | Price | $2.42 |
| Volume | 1.48M | Change | -1.63% |
| P/E Ratio | -4.3 | Open | $2.43 |
| Revenue | $1.3M | Prev Close | $2.46 |
| Net Income | $-161.7M | 52W Range | $1.01 - $3.31 |
| Div Yield | N/A | Target | $3.57 |
| Overall | 60 | Value | 60 |
| Quality | 31 | Technical | 91 |
No chart data available
Stock Overview
Updated DailyErasca Inc. (ERAS) is a leading Professional, Scientific, and Technical Services company in the Research and Development in Biotechnology industry, currently trading at $2.42 with a market capitalization of $692.16 million. The stock is positioned in the upper portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 31.
Today's trading session shows ERAS with a volume of 1.48 million shares. The stock opened down 1.22% from yesterday's close of $2.46. Current analyst estimates project earnings of $-0.44 per share for this year, with next year targeting $-0.45.
ERAS demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for ERAS include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 47.5%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 07:39 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ERAS | $2.42 | -1.6% | 1.48M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |